Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
66 participants
OBSERVATIONAL
2011-11-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Biomarkers to Screen for Obstructive Sleep Apnea
NCT04093102
Assessment of Obstructive Sleep Apnea Syndrome in Non-Obese Patients
NCT05814796
Obstructive Sleep Apnea in the Absence of Metabolic Syndrome
NCT01635010
Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea
NCT04712656
A Simplified Questionnaire to Detect OSA in COPD Patients
NCT01801761
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No treatment, OSA (AHI >15)
Patients with OSA recruited prior to receiving NHS treatment.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not received any treatment for Obstructive Sleep Apnea.
* Is a non-smoker
* Is not epileptic
* Epworth Sleepiness Scale ≥ 10.
* Patient's on Statins or antihypertensive drugs are included as so frequent in OSA.
Exclusion Criteria
* Presence of significant or unstable Renal, Liver or Heart Failure.
* Receiving anti-diabetic treatment.
* Is a smoker.
* Is epileptic
* Presence of significant or unstable psychological morbidities.
18 Years
70 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bangor University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher MN Earing, MSc
Role: PRINCIPAL_INVESTIGATOR
School of Sport, Health and Exercise Sciences, Bangor University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Betsi Cadwaladr University Health Board
Bangor, Gwynedd, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Earing 11/WNo01/2
Identifier Type: OTHER
Identifier Source: secondary_id
REC No: 11/WNo:01/2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.